PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.13
ESG score 90-95% of MDGL's 60.31. Bill Ackman would demand clear ESG improvement catalysts.
53.68
Environmental score 80-90% of MDGL's 63.35. Walter Schloss would scrutinize carbon exposure and transition planning.
57.71
Similar social score to MDGL's 60.70. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
60.00
Governance score 1.1-1.2x MDGL's 56.88. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.